Use of Tocilizumab Drug Levels to Optimize Treatment in RA

NCT03895879 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Tocilizumab

Sponsor

Reade Rheumatology Research Institute

Collaborators

[object Object]